Physician profile
Hannah Mader
NPI 1922745280
$2,230.60
in general payments reported to CMS, 2019-2025
17 companies · $438 in 2025
The $438 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $107 · 2024: $1,686 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,230.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $539.66 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $505.73 | 2023-2025 | Entyvio, Gattex |
| Janssen Biotech, INC. | $283.88 | 2024-2025 | Tremfya, Stelara |
| Pfizer INC. | $177.22 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $109.04 | 2024-2025 | Dupixent |
| Aimmune Therapeutics, INC. | $99.74 | 2024-2025 | Zenpep |
| Madrigal Pharmaceuticals | $99.01 | 2024-2025 | Resmetirom, Rezdiffra |
| Celltrion USA INC. | $84.11 | 2024-2025 | Vegzelma, Zymfentra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.79 | 2024-2025 | Xifaxan, Trulance |
| Genzyme Corporation | $51.70 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $50.50 | 2024 | Iqirvo |
| Ardelyx, INC. | $39.15 | 2024-2025 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $34.43 | 2024 | |
| Orphalan INC | $33.38 | 2025 | Cuvrior |
| Qol Medical, LLC | $23.30 | 2023 | Sucraid |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.26 | 2024 | Omvoh |
| Phathom Pharmaceuticals, INC. | $14.70 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Mader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.